News

Boston Business Journal

Health software startup PatientPing plans to hire 100, doubling size in 2019

Fierce Biotech

Orchard Therapeutics’ 2019: Pipeline progress, breaking ground on its $90M manufacturing site

Boston Business Journal

Health software startup PatientPing plans to hire 100, doubling size in 2019

PR Newswire

OTA Insight Expands Partnership with NH Hotel Group

Forbes

Plaid Buys Quovo In Its First Major Acquisition

PR Newswire

Adagene Announces Collaboration for Discovery of Novel CAR-T with the National Heart, Lung, and Blood Institute at the National Institutes of Health (NIH)

PR Newswire

Sana Biotechnology Launches Focusing on Engineering Cells to Create a New Class of Medicines

PR Newswire

Avidity Biosciences’ Arthur A. Levin Publishes Review of Therapeutic Approaches of Targeting RNA in the New England Journal of Medicine

PR Newswire

Mercy Health Network Partners with PatientPing to Improve Transitions of Care Across Iowa

Citizen Tribune

Precision BioSciences Appoints Rare Disease Executive Shalini Sharp to Its Board of Directors

Business Wire

CynergisTek and Protenus Join Forces as Partners to Protect Patient Privacy

Globe Newswire

Cytek Biosciences Ships 100th Advanced Flow Cytometry System

Business Wire

AvantStay Secures $5M in Funding to Deliver Short-term Group Rental Experiences

Business Wire

Compass Therapeutics Expands Leadership Team with Appointments of Chief Medical Officer and Chief Financial Officer

Business Wire

Semma Therapeutics Expands Executive Leadership Team

Carestack

CareStack® Announces Partnership with DentalXChange to Help Dental Practices Speed Claims Processing and Enhance Administrative Workflows

PRNewswire

Devoted Health Expands Provider Network With Top Hospitals in Lakeland Area

PRNewswire

Innovent and Incyte Announce Strategic Collaboration and Licensing Agreement for Three Clinical-stage Product Candidates in China

Business Insider

VitalWare™ Introduces HospitalPriceIndex.com In Response To Governmental Pricing Transparency Mandate

B3C Newswire

Orchard Therapeutics and SIRION Biotech Announce Licensing Agreement to Enhance Gene Therapy Manufacturing Efficiency

Nasdaq

Orchard Therapeutics Announces the Build-out of New Gene Therapy Manufacturing Facility in California

Business Wire

Caribou Biosciences Appoints Dr. Natalie Sacks to Board of Directors

Business Wire

Checkmate Pharmaceuticals Announces CEO Transition and $22 Million Financing

PRNewswire

Innovent Announces Two Clinical Studies with the Anti-VEGF Monoclonal Antibody IBI305, a Biosimilar Candidate to Avastin (Bevacizumab), Met Primary Endpoints

PRNewswire

OTA Insight appoints General Manager to drive continued growth in the Americas

Globe Newswire

Menlo Therapeutics’ Successful Phase 2 Clinical Trial of Serlopitant Demonstrates Reduction of Pruritus Associated with Psoriasis

Market Screener

Genomics plc Announces second close of Series B financing, raising a further £8m, bringing the total round to £33m

Globe Newswire

Denali Therapeutics Announces First Patient Dosed in Phase 1b Study of DNL201 for Parkinson’s Disease

Business Wire

Precision BioSciences and Durham STEM Students Lead Launch of First Genome Editing Experiment Into Space

Globe Newswire

Unum Therapeutics Inc. (UMRX) Secures U.S. Patent for ACTR Technology

Globe Newswire

Donald B. Kohn, MD, Orchard Therapeutics Scientific Advisory Board Member, Presents Clinical Proof-of-Concept Data for OTL-102 Gene Therapy for the Treatment of Patients with X-CGD at the Presidential Symposium at the 2018 ASH Annual Meeting

WealthManagement.com

Vestwell Inks a Deal With BNY Mellon

Biospace

Innovent Receives an Approval from the US FDA to Initiate Clinical Trials for its Anti-OX40 Monoclonal Antibody IBI101

Business Wire

Turnstone Biologics Unveils Novel Vaccinia Oncolytic Viral Immunotherapy Platform

BC Extra

Chi-Med, Innovent Enter Global Cancer Partnership

PRNewswire

Innovent Announces Global Collaboration with Hutchison MediPharma to Evaluate Combination of Sintilimab and Fruquintinib in Solid Tumors

Business Wire

Precision BioSciences Receives FDA Authorization to Initiate Clinical Study of Gene Edited Cancer Immunotherapy

PRNewswire

Blue Cross Blue Shield of Massachusetts Expands Medicare Network to Include Iora Health

PRNewswire

TraceLink Achieves 55% Overall Revenue Growth for Q3 2018

PRNewswire

Promentis Pharmaceuticals Announces Successful Completion of Phase 1 Studies for SXC-2023 Targeting Novel Glutamatergic Mechanism

Flywire Introduces Payment Plan Management for UK Educational Institutions

CareStack® Partners with Callpop to Expand Patient Communication Capabilities for Dental Practices Nationwide

Precision BioSciences and MaxCyte Enter into Clinical and Commercial License Agreement

PRNewswire

Zeel Partners With Stride Health To Bridge Insurance Gap For Massage Therapists

Globe Newswire

Cytek Biosciences Continues Momentum by Strengthening Executive Team, Adding Board Members

Tempest Therapeutics Reports Proof of Mechanism Data for First-in-Class PPAR Alpha Antagonist

Modis Therapeutics Announces Prime Designation Granted by the European Medicines Agency to MT1621 for the Treatment of TK2 Deficiency

PRNewswire

NMPA Accepts Biosimilar New Drug Application for IBI303, a Biosimilar Candidate to Humira(R) (adalimumab)

Globe Newswire

Unum Therapeutics to Present Preclinical Data on Applications of ACTR Proprietary Technology Platform in Solid Tumors at the San Antonio Breast Cancer Symposium

Innovent Highlights Clinical Data of Anti-PD-1 Antibody Sintilimab in Patients with First-line Squamous NSCLC

Threat Stack Announces Acquisition of Runtime Application Security Vendor, Bluefyre

B3C Newswire

Orchard Therapeutics Strengthens Global Commercial Leadership Team with Appointments of Heads of US and EMEA Region Commercial Operations

PRNewswire

Maine’s Northern Light Beacon Health Partners with PatientPing to Coordinate Care for Patients Throughout the State — and Beyond

Globe Newswire

Unum Therapeutics to Present Preclinical Data on a New, Emerging Platform Technology for Solid Tumors at the SITC Annual Meeting

Business Wire

Health First Selects Kyruus Solutions to Enable Digital Patient Access Initiatives

Business Wire

Health First Selects Kyruus Solutions to Enable Digital Patient Access Initiatives

Business Wire

Compass Therapeutics Announces Preclinical Data on Lead Antibody Program and NK Cell Engager Platform to be Presented at the Society for Immunotherapy of Cancer Annual Meeting

B3C Newswire

Orchard Therapeutics Announces Closing of $225 Million Initial Public Offering, Including the Partial Exercise of Underwriters’ Option

Globe Newswire

Denali Therapeutics Announces Broad Collaboration with Sanofi to Develop RIPK1 Inhibitors for the Treatment of Neurological and Inflammatory Diseases

PRNewswire

PatientPing Expands Care Coordination Offering to Help Organizations Succeed Under BPCI Advanced

Reuters

China’s Innovent Biologics Makes 5 Percent Gain in Hong Kong Debut

PRNewswire

Adagene Announces First Patient Dosed in United States and Acceptance of IND in China for ADG-106

PRNewswire

RiskRecon Recognized as One of Utah’s Emerging Elite Companies

Globe Newswire

Orchard Therapeutics Announces Pricing of Initial Public Offering

PRNewswire

Snapsheet Named to CB Insights Fintech 250 List of Fastest-growing Startups

Innovent Biologics Raises $421 Million in Hong Kong IPO

Business Wire

Innovusion Raises US $30M in Series A Round and Starts Shipping the World’s First Image-Grade LiDAR System for Autonomous Vehicles

Globe Newswire

Cytek Biosciences Debuts Advanced Flow Cytometry System that Breaks the Cost Barrier

Business Wire

Kyruus Announces Launch of ProviderMatch for Salesforce on the Salesforce AppExchange to Help Health Systems Deliver Optimal Access Experience

Gene therapy biotech Orchard Therapeutics sets terms for $200 million IPO

PRNewswire

US HealthVest is Developing a New Behavioral Hospital on Hendricks Regional Health Plainfield Campus

Devoted Health, New Medicare Advantage Business, Raises $300 Million

PRNewswire

TraceLink Announces Availability of End-to-End DSCSA Saleable Returns Verification Solution for Pharmaceutical Manufacturers and Wholesale Distributors

Globe Newswire

Flywire Makes Cross-Border Payments from India Easier

PRNewswire

PatientPing’s National Community of ACO Providers Generate More than $270 Million in Shared Savings

Business Wire

Buoy Health Named to CNBC’s 2018 Upstart 100 List Highlighting Innovation and Rapid Growth

PRNewswire

FAREVA Selects TraceLink to Comply with EU FMD Regulations

Orchard Therapeutics plans $172.5 million U.S. IPO

Globe Newswire

Carbonite CEO Mohamad Ali, CarGurus and Flywire Take Top Honors at 21st Annual Mass Technology Leadership Awards

Globe Newswire

Carbonite CEO Mohamad Ali, CarGurus and Flywire Take Top Honors at 21st Annual Mass Technology Leadership Awards

Business Wire

Buoy Health Receives Robert Wood Johnson Foundation Artificial Intelligence Award for Patient Health Education

TraceLink Surpasses 1,000 Customer Milestone, Including Over 500 Pharmaceutical Manufacturing Companies

Centogene, Denali Therapeutics Partner to Recruit Parkinson’s Patients for Drug Program

FierceBiotech Names Compass Therapeutics a 2018 “Fierce 15” Biotech Company

Notable Health Named an IDC Innovator for Enterprise Wearable Software Solutions in Health Care

Modis Therapeutics Announces $30M Series A Financing

Pharmeasy raises $50 million in Series C funding

Innovent Receives an Approval from the US FDA to Initiate Clinical Trials for its Anti-CD47 Monoclonal Antibody IBI-188

Akrevia Therapeutics Launches with $30M Series A Financing Led by F-Prime Capital Partners and Atlas Venture

NodThera announces the appointment of Adam Keeney PhD as President and Chief Executive Officer